139 related articles for article (PubMed ID: 12549942)
1. Effect of clarithromycin on steady-state digoxin concentrations.
Tanaka H; Matsumoto K; Ueno K; Kodama M; Yoneda K; Katayama Y; Miyatake K
Ann Pharmacother; 2003 Feb; 37(2):178-81. PubMed ID: 12549942
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of the clarithromycin-digoxin interaction in elderly patients.
Zapater P; Reus S; Tello A; Torrús D; Pérez-Mateo M; Horga JF
J Antimicrob Chemother; 2002 Oct; 50(4):601-6. PubMed ID: 12356809
[TBL] [Abstract][Full Text] [Related]
3. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
Wakasugi H; Yano I; Ito T; Hashida T; Futami T; Nohara R; Sasayama S; Inui K
Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727
[TBL] [Abstract][Full Text] [Related]
4. The effect of erythromycin and clarithromycin on the pharmacokinetics of intravenous digoxin in healthy volunteers.
Tsutsumi K; Kotegawa T; Kuranari M; Otani Y; Morimoto T; Matsuki S; Nakano S
J Clin Pharmacol; 2002 Oct; 42(10):1159-64. PubMed ID: 12362931
[TBL] [Abstract][Full Text] [Related]
5. Interactions between clarithromycin and digoxin in patients with end-stage renal disease.
Hirata S; Izumi S; Furukubo T; Ota M; Fujita M; Yamakawa T; Hasegawa I; Ohtani H; Sawada Y
Int J Clin Pharmacol Ther; 2005 Jan; 43(1):30-6. PubMed ID: 15704612
[TBL] [Abstract][Full Text] [Related]
6. Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literature.
Lee CY; Marcotte F; Giraldeau G; Koren G; Juneau M; Tardif JC
Can J Cardiol; 2011; 27(6):870.e15-6. PubMed ID: 21907534
[TBL] [Abstract][Full Text] [Related]
7. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Ludwig J; Weiss J; Mikus G; Walter-Sack I; Haefeli WE
Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773
[TBL] [Abstract][Full Text] [Related]
8. Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study.
Chan AL; Wang MT; Su CY; Tsai FH
Eur J Clin Pharmacol; 2009 Dec; 65(12):1237-43. PubMed ID: 19655133
[TBL] [Abstract][Full Text] [Related]
9. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
10. Digoxin toxicity secondary to clarithromycin therapy.
Nawarskas JJ; McCarthy DM; Spinler SA
Ann Pharmacother; 1997; 31(7-8):864-6. PubMed ID: 9220047
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral cibenzoline on steady-state digoxin concentrations in healthy volunteers.
Khoo KC; Givens SV; Parsonnet M; Massarella JW
J Clin Pharmacol; 1988 Jan; 28(1):29-35. PubMed ID: 3350991
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of enoximone on the pharmacokinetics of digoxin in patients with congestive heart failure.
Trenk D; Hertrich F; Winkelmann B; Glauner T; Dieterich HA; Jähnchen E
J Clin Pharmacol; 1990 Mar; 30(3):235-40. PubMed ID: 2138170
[TBL] [Abstract][Full Text] [Related]
13. Diltiazem increases steady state digoxin serum levels in patients with cardiac disease.
Andrejak M; Hary L; Andrejak MT; Lesbre JP
J Clin Pharmacol; 1987 Dec; 27(12):967-70. PubMed ID: 3437068
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction of sparfloxacin and digoxin.
Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
[TBL] [Abstract][Full Text] [Related]
15. Two cases of clarithromycin-induced digoxin toxicity.
Guerriero SE; Ehrenpreis E; Gallagher KL
Pharmacotherapy; 1997; 17(5):1035-7. PubMed ID: 9324195
[TBL] [Abstract][Full Text] [Related]
16. Nicardipine does not significantly affect serum digoxin concentrations at the steady state of patients with congestive heart failure.
Debruyne D; Commeau P; Grollier G; Huret B; Scanu P; Moulin M
Int J Clin Pharmacol Res; 1989; 9(1):15-9. PubMed ID: 2707921
[TBL] [Abstract][Full Text] [Related]
17. Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin.
Gooderham MJ; Bolli P; Fernandez PG
Ann Pharmacother; 1999; 33(7-8):796-9. PubMed ID: 10466907
[TBL] [Abstract][Full Text] [Related]
18. Absence of pharmacokinetic interaction between roflumilast and digoxin in healthy adults.
Eckermann G; Lahu G; Nassr N; Bethke TD
J Clin Pharmacol; 2012 Feb; 52(2):251-7. PubMed ID: 21257799
[TBL] [Abstract][Full Text] [Related]
19. Effect of lasofoxifene on the pharmacokinetics of digoxin in healthy postmenopausal women.
Roman D; Bramson C; Ouellet D; Randinitis E; Gardner M
J Clin Pharmacol; 2005 Dec; 45(12):1407-12. PubMed ID: 16291716
[TBL] [Abstract][Full Text] [Related]
20. Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans.
Gurley BJ; Barone GW; Williams DK; Carrier J; Breen P; Yates CR; Song PF; Hubbard MA; Tong Y; Cheboyina S
Drug Metab Dispos; 2006 Jan; 34(1):69-74. PubMed ID: 16221754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
